Characteristics and Clinical Course of STEMI Patients who Received no Reperfusion in the Australia and New Zealand SNAPSHOT ACS Registry

Heart Lung and Circulation

Volumn 25, Issue 2, 2016, Pages 132-139

  Farshid, Ahmad ^a   Brieger, David ^b   Hyun, Karice ^c   Hammett, Christopher ^d   Ellis, Christopher ^e   Rankin, Jamie ^f   Lefkovits, Jeff ^g   Chew, Derek ^h   French, John ⁱ  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f FIONA STANLEY HOSPITAL   (Australia)

^g ROYAL MELBOURNE HOSPITAL   (Australia)

^h FLINDERS MEDICAL CENTRE   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Primary percutaneous coronary intervention; Reperfusion therapy; ST elevation myocardial infarction; Thrombolysis

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATRIAL FIBRILLATION; AUSTRALIA; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; FEMALE; FIBRINOLYSIS; HEART FAILURE; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADVERSE EFFECTS; AGE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; HOSPITAL MORTALITY; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATION; REGISTER; RENAL INSUFFICIENCY, CHRONIC; SURVIVAL RATE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; NEW ZEALAND; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; SURVIVAL RATE;

EID: 84954198003     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.08.004     Document Type: Article

References (19)

1. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 61:e78-e140.
2. Steg P.G., James S.K., Atar D., Badano L.P., Blomstrom-Lundqvist C., Borger M.A., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2012, 33:2569-2619.
3. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994, 343:311-322. Group FTTFC.
4. Eagle K.A., Nallamothu B.K., Mehta R.H., Granger C.B., Steg P.G., Van de Werf F., et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. European Heart Journal. 2008, 29:609-617.
5. Cohen M., Gensini G.F., Maritz F., Gurfinkel E.P., Huber K., Timerman A., et al. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation. 2003, 108. III14-21.
6. Gharacholou S.M., Alexander K.P., Chen A.Y., Wang T.Y., Melloni C., Gibler W.B., et al. Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative. Am Heart J. 2010, 159:757-763.
7. Gibson C.M., Pride Y.B., Frederick P.D., Pollack C.V., Canto J.G., Tiefenbrunn A.J., et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008, 156:1035-1044.
8. Huynh L.T., Rankin J.M., Tideman P., Brieger D.B., Erickson M., Markwick A.J., et al. Reperfusion therapy in the acute management of ST-segment-elevation myocardial infarction in Australia: findings from the ACACIA registry. The Medical Journal of Australia. 2010, 193:496-501.
9. French J.K., Williams B.F., Hart H.H., Wyatt S., Poole J.E., Ingram C., et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ. 1996, 312:1637-1641.
10. Granger C.B., Goldberg R.J., Dabbous O., Pieper K.S., Eagle K.A., Cannon C.P., et al. Predictors of hospital mortality in the global registry of acute coronary events. Archives of Internal Medicine. 2003, 163:2345-2353.
11. Shahzad A., Kemp I., Mars C., Wilson K., Roome C., Cooper R., et al. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 2014, 384:1849-1858.
12. Stone G.W., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., et al. Bivalirudin during primary PCI in acute myocardial infarction. The New England Journal of Medicine. 2008, 358:2218-2230.
13. Schiele F., Hochadel M., Tubaro M., Meneveau N., Wojakowski W., Gierlotka M., et al. Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. European Heart Journal. 2010, 31:2614-2624.
14. O'Brien E.C., Rose K.M., Suchindran C.M., Sturmer T., Chang P.P., Chambless L., et al. Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction. Heart. 2013, 99:767-773.
15. Farshid A., Allada C., Chandrasekhar J., Marley P., McGill D., O'Connor S., et al. Shorter ischaemic time and improved survival with pre-hospital STEMI diagnosis and direct transfer for primary PCI. Heart, Lung and Circulation. 2015, 24:234-240.
16. Luepker R.V., Raczynski J.M., Osganian S., Goldberg R.J., Finnegan J.R., Hedges J.R., et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial. JAMA: the journal of the American Medical Association 2000, 284:60-67.
17. Tummala S.R., Farshid A. Patients' understanding of their heart attack and the impact of exposure to a media campaign on pre-hospital time. Heart, Lung and Circulation. 2015, 24:4-10.
18. White H.D. Thrombolytic therapy in the elderly. Lancet. 2000, 356:2028-2030.
19. Armstrong P.W., Gershlick A.H., Goldstein P., Wilcox R., Danays T., Lambert Y., et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. The New England Journal of Medicine. 2013, 368:1379-1387.